X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52120) 52120
Book Review (12194) 12194
Newsletter (8683) 8683
Publication (5063) 5063
Newspaper Article (3093) 3093
Book Chapter (185) 185
Conference Proceeding (174) 174
Book / eBook (112) 112
Magazine Article (110) 110
Dissertation (41) 41
Government Document (28) 28
Trade Publication Article (8) 8
Web Resource (8) 8
Data Set (4) 4
Paper (4) 4
Presentation (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (46355) 46355
humans (46030) 46030
male (36375) 36375
prostate cancer (32600) 32600
cancer (23300) 23300
oncology (20921) 20921
prostatic neoplasms - drug therapy (17791) 17791
research (14562) 14562
animals (12934) 12934
care and treatment (12349) 12349
prostatic neoplasms - pathology (12349) 12349
aged (12090) 12090
middle aged (10846) 10846
cell line, tumor (10574) 10574
prostate-cancer (9964) 9964
metastasis (8350) 8350
oncology, experimental (8260) 8260
female (8258) 8258
apoptosis (7411) 7411
mice (7155) 7155
urology & nephrology (6982) 6982
prostatic neoplasms - metabolism (6123) 6123
health aspects (6101) 6101
prostate (6004) 6004
chemotherapy (5662) 5662
tumors (5611) 5611
expression (5573) 5573
analysis (5175) 5175
drug therapy (5005) 5005
aged, 80 and over (4907) 4907
antineoplastic agents - therapeutic use (4741) 4741
treatment outcome (4634) 4634
breast-cancer (4614) 4614
carcinoma (4300) 4300
apoptosis - drug effects (4286) 4286
antineoplastic agents - pharmacology (4276) 4276
reports (4241) 4241
development and progression (4173) 4173
cancer therapies (4167) 4167
prognosis (3988) 3988
androgens (3971) 3971
article (3841) 3841
genetic aspects (3840) 3840
prostatic neoplasms - genetics (3838) 3838
therapy (3789) 3789
prostatic neoplasms - therapy (3727) 3727
gene expression (3694) 3694
cell proliferation - drug effects (3661) 3661
androgen antagonists - therapeutic use (3652) 3652
proteins (3633) 3633
adult (3630) 3630
radiotherapy (3534) 3534
abridged index medicus (3482) 3482
biochemistry & molecular biology (3478) 3478
pharmacology & pharmacy (3435) 3435
risk factors (3366) 3366
prostate-specific antigen - blood (3271) 3271
breast cancer (3247) 3247
cell biology (3225) 3225
growth (3049) 3049
prostatic neoplasms - surgery (2947) 2947
prostatic neoplasms - radiotherapy (2913) 2913
mice, nude (2902) 2902
neoplasms - drug therapy (2901) 2901
medicine (2887) 2887
cells (2799) 2799
signal transduction (2773) 2773
survival (2772) 2772
urology (2765) 2765
gene expression regulation, neoplastic (2666) 2666
neoplasm metastasis (2643) 2643
disease progression (2627) 2627
drugs (2622) 2622
tumor cells, cultured (2608) 2608
medical research (2606) 2606
prostatic neoplasms - blood (2554) 2554
research article (2521) 2521
antineoplastic agents, hormonal - therapeutic use (2459) 2459
men (2437) 2437
bone neoplasms - secondary (2433) 2433
in-vitro (2412) 2412
antineoplastic combined chemotherapy protocols - therapeutic use (2343) 2343
xenograft model antitumor assays (2331) 2331
time factors (2299) 2299
endocrinology & metabolism (2292) 2292
neoplasm staging (2292) 2292
universities and colleges (2284) 2284
clinical trials (2259) 2259
antineoplastic agents (2255) 2255
cell proliferation (2253) 2253
adenocarcinoma - drug therapy (2246) 2246
prostatic neoplasms - mortality (2239) 2239
diagnosis (2217) 2217
androgen receptor (2210) 2210
in-vivo (2207) 2207
progression (2192) 2192
studies (2190) 2190
radical prostatectomy (2188) 2188
medicine & public health (2186) 2186
kinases (2182) 2182
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (77) 77
Online Resources - Online (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Markham Stouffville Hospital - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Gerstein Science - Withdrawn (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (61495) 61495
Japanese (750) 750
French (578) 578
German (547) 547
Spanish (227) 227
Russian (141) 141
Chinese (108) 108
Italian (108) 108
Polish (38) 38
Danish (33) 33
Swedish (31) 31
Hungarian (29) 29
Dutch (26) 26
Czech (23) 23
Norwegian (22) 22
Hebrew (17) 17
Bulgarian (12) 12
Finnish (9) 9
Portuguese (8) 8
Turkish (7) 7
Afrikaans (5) 5
Croatian (5) 5
Korean (5) 5
Romanian (5) 5
Serbian (5) 5
Ukrainian (2) 2
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 75 - 87
Summary Background Poly(ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian carcinomas with homologous recombination deficiency. Along with BRCA1... 
Hematology, Oncology and Palliative Medicine | BRCA MUTATION | POLY(ADP-RIBOSE) POLYMERASE | RANDOMIZED PHASE-2 | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTANT-CELLS | PROSTATE-CANCER | INHIBITORS | DNA-REPAIR | NEGATIVE BREAST-CANCER | GENOMIC LOSS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 3, pp. 244 - 250
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 19, pp. 3167 - 3175
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 69, Issue 1, pp. 9 - 12
Journal Article
Nature, ISSN 0028-0836, 07/2017, Volume 547, Issue 7664, pp. 453 - 457
Plasticity of the cell state has been proposed to drive resistance to multiple classes of cancer therapies, thereby limiting their effectiveness(1-4). A... 
EPITHELIAL-MESENCHYMAL TRANSITION | METABOLISM | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | HUMAN-MELANOMA CELLS | SENSITIVITY | DEATH | INHIBITOR | EXPRESSION | SIGNATURE | REVEALS | Prostatic Neoplasms - metabolism | Cadherins - metabolism | Humans | Mesoderm - drug effects | Melanoma - enzymology | Male | Lipid Peroxides - metabolism | Zinc Finger E-box-Binding Homeobox 1 - genetics | Neoplasms - genetics | Mesoderm - enzymology | Cell Death | Epithelial-Mesenchymal Transition | Lipid Peroxidation - drug effects | Cell Transdifferentiation | Prostatic Neoplasms - drug therapy | Melanoma - metabolism | Glutathione Peroxidase - metabolism | Prostatic Neoplasms - pathology | Reproducibility of Results | Neoplasms - enzymology | Melanoma - pathology | Iron - metabolism | Neoplasms - drug therapy | Cell Lineage | Drug Resistance, Neoplasm - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Proteomics | Cell Line, Tumor | Prostatic Neoplasms - enzymology | Mesoderm - metabolism | Neoplasms - pathology | Mesoderm - pathology | Peroxidase | Research | Chemical properties | Chemical synthesis | Analysis | Cancer cells | Therapy | Biotechnology | Carcinoma | Mesenchyme | Genes | Lipid peroxidation | Lipids | Iron | Genomes | Phospholipids | Kinases | Cancer therapies | Proteins | Organoids | Dissipation | Peroxides | Lipid metabolism | Glutathione | Transfer RNA | Peroxidation | Glutathione peroxidase | Enzymes | Mortality | Melanoma | Selenocysteine | Tumor cell lines | Metabolism | Substrates | Cell death | Lipoxygenase | Prostate cancer | Prostate | Tumors | Apoptosis | Cancer | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 882 - 892
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 2, pp. 152 - 160
Journal Article